New selective medium for isolating Clostridium difficile from faeces
- PMID: 1401214
- PMCID: PMC495111
- DOI: 10.1136/jcp.45.9.812
New selective medium for isolating Clostridium difficile from faeces
Abstract
Aims: To compare CCFA (cycloserine, cefoxitin fructose agar) with a new selective medium CDMN (containing cysteine hydrochloride, norfloxacin, and moxalactam) for the isolation of Clostridium difficile after direct faecal culture.
Methods: The minimum inhibitory concentration (MIC) of norfloxacin was determined for 64 strains of C difficile, 17 strains of other Clostridium sp, and 66 various isolates of faecal origin, together with MIC determinations of moxalactam against the 81 strains of Clostridium sp and 15 isolates of Bacteroides sp. Using C difficile agar base with 0.5 g/l of cysteine hydrochloride, norfloxacin and moxalactam were incorporated into the medium and compared with CCFA for the isolation of C difficile after direct faecal culture.
Results: Norfloxacin (12 mg/l) inhibited the growth of enterobacteriaceae and faecal streptococci; moxalactam (32 mg/l) inhibited the growth of most strains of Bacteroides sp tested, together with Clostridium sp other than C difficile. Using the antibiotics in combination (CDMN), the growth and colonial morphology of 64 strains of C difficile were unaffected. When CDMN medium was compared with CCFA for the isolation of C difficile from 832 faeces from inpatients with diarrhoea, the CDMN agar isolated 20% more strains and reduced the number of contaminating colonies by 30%.
Conclusions: CDMN both improves the isolation rate of C difficile from faecal specimens and reduces the growth of other organisms compared with CCFA.
Similar articles
-
Isolation of Clostridium difficile from faecal specimens--a comparison of chromID C. difficile agar and cycloserine-cefoxitin-fructose agar.J Med Microbiol. 2013 Sep;62(Pt 9):1423-1427. doi: 10.1099/jmm.0.056515-0. Epub 2013 Apr 11. J Med Microbiol. 2013. PMID: 23579394
-
Comparison of cycloserine-cefoxitin-fructose agar (CCFA) and taurocholate-CCFA for recovery of Clostridium difficile during surveillance of hospitalized patients.Diagn Microbiol Infect Dis. 1997 Sep;29(1):1-4. doi: 10.1016/s0732-8893(97)00113-2. Diagn Microbiol Infect Dis. 1997. PMID: 9350408
-
Evaluation of cycloserine-cefoxitin fructose agar (CCFA), CCFA with horse blood and taurocholate, and cycloserine-cefoxitin mannitol broth with taurocholate and lysozyme for recovery of Clostridium difficile isolates from fecal samples.J Clin Microbiol. 2013 Sep;51(9):3094-6. doi: 10.1128/JCM.00879-13. Epub 2013 Jun 26. J Clin Microbiol. 2013. PMID: 23804392 Free PMC article.
-
Improvement of Clostridium difficile isolation by heat-shock and typing of the isolated strains by SDS-PAGE.Eur J Epidemiol. 1993 May;9(3):327-34. doi: 10.1007/BF00146272. Eur J Epidemiol. 1993. PMID: 8405320
-
Improved recovery of Clostridium difficile spores with the incorporation of synthetic taurocholate in cycloserine-cefoxitin-fructose agar (CCFA).Pathology. 2012 Jun;44(4):354-6. doi: 10.1097/PAT.0b013e328353a235. Pathology. 2012. PMID: 22531346
Cited by
-
Characterization of toxin A-negative, toxin B-positive Clostridium difficile isolates from outbreaks in different countries by amplified fragment length polymorphism and PCR ribotyping.J Clin Microbiol. 2004 Mar;42(3):1035-41. doi: 10.1128/JCM.42.3.1035-1041.2004. J Clin Microbiol. 2004. PMID: 15004050 Free PMC article.
-
Evaluation of an algorithmic approach in comparison with the Illumigene assay for laboratory diagnosis of Clostridium difficile infection.J Clin Microbiol. 2013 Apr;51(4):1152-7. doi: 10.1128/JCM.03203-12. Epub 2013 Jan 30. J Clin Microbiol. 2013. PMID: 23363829 Free PMC article.
-
Effective and reduced-cost modified selective medium for isolation of Clostridium difficile.J Clin Microbiol. 2009 Feb;47(2):397-400. doi: 10.1128/JCM.01591-08. Epub 2008 Dec 10. J Clin Microbiol. 2009. PMID: 19073869 Free PMC article.
-
Evaluation of three enzyme immunoassays and a loop-mediated isothermal amplification test for the laboratory diagnosis of Clostridium difficile infection.Eur J Clin Microbiol Infect Dis. 2012 Nov;31(11):3035-9. doi: 10.1007/s10096-012-1658-y. Epub 2012 Jun 17. Eur J Clin Microbiol Infect Dis. 2012. PMID: 22706512
-
Culture-independent detection of low-abundant Clostridioides difficile in environmental DNA via PCR.Appl Environ Microbiol. 2024 Mar 20;90(3):e0127823. doi: 10.1128/aem.01278-23. Epub 2024 Feb 9. Appl Environ Microbiol. 2024. PMID: 38334406 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases